Skip to main content
IKDS 2024 Main banner
Icon Legend

  1. Home

  • Monday, Aug 26th
    3:15 PM – 4:00 PM East Coast USA Time
    23 - EFFICACY OF ANGIOTENSIN II RECEPTOR BLOCKER/ANGIOTENSIN CONVERTING ENZYME FOR CORONARY ARTERY ANEURYSM REGRESSION IN JAPANESE PATIENT WITH KAWASAKI DISEASE
    Location: Outremont
    Author: Eisuke Suganuma, M.D., Ph.D. – Division of Infectious Diseases, and Immunology, Allergy, Saitama Children's Medical Center
    Therapeutics
  • Monday, Aug 26th
    3:15 PM – 4:00 PM East Coast USA Time
    43 - A PHASE I/IIA TRIAL OF ATROVASTATIN IN JAPANESE PATIENTS WITH ACUTE KAWASAKI DISEASE AND CORONARY ARTERY ANEURYSMS: A MULTICENTER, SINGLE-ARM, OPEN-LABEL TRIAL
    Location: Outremont
    Author: KENJI FURUNO, MD – Fukuoka Children's Hospital and Japanese Red Cross Fukuoka Hospital
    Therapeutics
  • Monday, Aug 26th
    3:15 PM – 4:00 PM East Coast USA Time
    140 - PROMOTING ENDOTHELIAL CELL HEALTH AFTER KAWASAKI DISEASE: PEACH STUDY
    Location: Outremont
    Author: Koichi MIYATA, MD – Department of Pediatrics, University of California San Diego
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    8 - HYDROGEN GAS INHALATION IMPROVE CORONARY ARTERY DILATION IN A MICE MODEL OF KAWASAKI DISEASE
    Location: St-Laurent
    Author: HO-CHANG KUO, n/a – Kawasaki disease center, Kaohsiung Chang Gung Memorial Hospital, Taiwan
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    12 - VERY LONG-TERM OUTCOME OF TRANSCATHETER POLYTETRAFLUOROETHYLENE-COVERED STENT IMPLANTATION IN A GIANT CORONARY ANEURYSM IN A CHILD WITH KAWASAKI DISEASE
    Location: Poster hall
    Author: Kenji Waki, n/a – Department of Pediatrics, Kurashiki Central Hospital
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    33 - UNUSUAL PRESENTATION AND COURSE OF SEVERE INFANTILE KAWASAKI DISEASE TREATED WITH IL-1 ANTAGONISTS
    Location: St-Laurent
    Author: EMILY DUAN, MD – UCLA
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    44 - A PILOT STUDY ON CLINICAL SAFETY AND EFFICACY OF COMBINATION THERAPY WITH COLCHICINE AND INTRAVENOUS IMMUNOGLOBULIN FOR KAWASAKI DISEASE
    Location: St-Laurent
    Author: Kentaro Aso, n/a – St. Marianna University School of Medicine, Department of Pediatrics
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    46 - RISK FACTORS OF REFRACTORY KAWASAKI DISEASE IN LOW-RISK IVIG NONRESPONSE PREDICTION SCORE GROUP
    Location: St-Laurent
    Author: NATSUMI WATANABE, n/a – Pediatrics
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    61 - MID-TERM FOLLOW-UP OF CORONARY ARTERY ANGIOPLASTY IN CHILDREN WITH GIANT CORONARY ARTERY ANEURYSM AFTER KAWASAKI DISEASE: A SINGLE-CENTER CASE SERIES OF 5 CASES
    Location: St-Laurent
    Author: FANG LIU, n/a – Cardiac Center, Children’s Hospital of Fudan University
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    110 - VARIATION IN TREATMENT APPROACHES TO KD AMONG PEDIATRIC RHEUMATOLOGISTS: THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE (CARRA) TREATMENT OF REFRACTORY KD SURVEY
    Location: St-Laurent
    Author: CAGRI YILDIRIM-TORUNER, MD – Baylor College of Medicine/ Texas Children's Hospital
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    146 - 7-MONTH-OLD INFANT WITH INCOMPLETE KAWASAKI DISEASE, GIANT CORONARY ARTERY ANEURYSM, CORONARY ARTERY THROMBUS: CHALLENGES IN MANAGEMENT DURING THE ACUTE PHASE
    Location: St-Laurent
    Author: PALLAVI L. NADIG, MD – ALLERGY IMMUNOLOGY UNIT, ADVANCED PEDIATRICS CENTER, POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    158 - CICLOSPORIN IS USEFUL IN SEVERE KAWASAKI DISEASE: EXPERIENCE FROM A TERTIARY CARE CENTRE IN NORTH-WEST INDIA
    Location: St-Laurent
    Author: GAYATHRI C V, MBBS, MD – Pediatric Allergy Immunology Unit, Department of Pediatrics, PGIMER, Chandigarh
    Therapeutics
  • Tuesday, Aug 27th
    4:10 PM – 4:30 PM East Coast USA Time
    208 - REFRACTORY KAWASAKI DISEASE, A CHALLENGE FOR MEDICINE
    Location: St-Laurent
    Author: ANA C. MUÑOZ, N/A, n/a – CAIC
    Therapeutics
  • Tuesday, Aug 27th
    4:45 PM – 5:30 PM East Coast USA Time
    77 - INHIBITION OF HIGH MOBILITY GROUP BOX-1 ATTENUATES IN THE LCWE-INDUCED MURINE MODEL OF KD VASCULITIS
    Location: Outremont
    Author: Kentaro Ueno, Doctor of Philosophy – Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences
    Therapeutics